Drug · DIN 02484153
FULPHILA
SINGLE-DOSE PREFILLED SYRINGES
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 14, 2026; first marketed February 7, 2020.
- Drug Identification Number (DIN)
- 02484153
- Company (DIN owner)
- Biocon Biologics Canada IncToronto, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Pegfilgrastim L03AA13
- Class
- Human
- Record last updated
- September 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PEGFILGRASTIM | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 14, 2026: NOC 38116New Drug Submission (NDS) · Administrative – Change in Product Ownership
- May 15, 2023: NOC 30774New Drug Submission (NDS) · Administrative - Change in Product Ownership
- December 24, 2018: NOC 21665New Drug Submission (NDS)